NCM
GSK icon

Northwest Capital Management’s GSK GSK Stock Holding History

Northwest Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-320
Closed -$12.3K – 285
2025
Q2 		$12.3K Hold
320
– – 0.01% 261
2025
Q1 		$12.4K Hold
320
– – 0.01% 295
2024
Q4 		$10.8K Hold
320
– – ﹤0.01% 304
2024
Q3 		$13.1K Hold
320
– – ﹤0.01% 303
2024
Q2 		$12.3K Hold
320
– – ﹤0.01% 301
2024
Q1 		$13.7K Hold
320
– – ﹤0.01% 349
2023
Q4 		$11.9K Hold
320
– – ﹤0.01% 356
2023
Q3 		$11.6K Hold
320
– – ﹤0.01% 346
2023
Q2 		$11.4K Buy
+320
New +$11.5K ﹤0.01% 357

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northwest Capital Management's GSK Position: Q3 2025 in Review

Northwest Capital Management sold out of GSK (GSK) in Q3 2025, closing a stake of 320 shares — an estimated $12.3K sold.

Northwest Capital Management first reported a position in GSK in Q2 2023 and held it in 9 quarters. The position peaked at $13.7K in Q1 2024. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Northwest Capital Management reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Northwest Capital Management sold 320 GSK shares in Q3 2025, an estimated $12.3K.
  • Northwest Capital Management first reported a position in GSK in Q2 2023 and held it in 9 quarters.
  • Northwest Capital Management's GSK position peaked at $13.7K in Q1 2024.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Northwest Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.